Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T22:28:55.761Z.
Calculation as of: 2026-10-06T22:28:55.761Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97452f2638ad5d60f1716ef7360feea6a822b872a50cf44a9ba771f9e60b5836
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Twist Bioscience Corporation
Market Cap
$10.40B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.31B
EV/EBIT Ratio
15.19x
TTM Avg
24.51x
3Y Avg
55.37x
5Y Avg
46.14x
Market Cap
$10.19B
EV/EBIT Ratio
30.93x
TTM Avg
14.47x
3Y Avg
11.64x
5Y Avg
12.65x
Market Cap
$10.13B
EV/EBIT Ratio
16.58x
TTM Avg
19.50x
3Y Avg
23.74x
5Y Avg
27.91x
Market Cap
$10.72B
EV/EBIT Ratio
7.70x
TTM Avg
8.63x
3Y Avg
11.13x
5Y Avg
11.58x
Market Cap
$10.03B
EV/EBIT Ratio
25.71x
TTM Avg
30.22x
3Y Avg
30.29x
5Y Avg
26.97x
Market Cap
$10.87B
EV/EBIT Ratio
51.95x
TTM Avg
25.50x
3Y Avg
52.86x
5Y Avg
123.66x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 15.19x | 24.51x | 55.37x | 46.14x |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | N/A | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 30.93x | 14.47x | 11.64x | 12.65x |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 16.58x | 19.50x | 23.74x | 27.91x |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 7.70x | 8.63x | 11.13x | 11.58x |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 25.71x | 30.22x | 30.29x | 26.97x |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 51.95x | 25.50x | 52.86x | 123.66x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 45.17x | 40.04x | 33.82x | 33.08x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
